Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ark Therapeutics
Ark Therapeutics
Activities:
Research & Development
X
LinkedIn
Trending Articles
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
Broughton receives flexible scope ISO 17025 accreditation
New certification allows accreditation without prior approval
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Ark Therapeutics makes a promotion
David Venables will become ceo on 1 August
Pharmaceutical
New head of business development for Ark
Kassim Kolia will build firm’s manufacturing services business at Finland facility
Research & Development
David Venables joins Ark Therapeutics
As executive director of manufacturing services
Manufacturing
Ark agrees manufacturing deal with Glasgow University
To support development of gene-therapy programme for treating vein graft failure
Manufacturing
Ark and PsiOxus sign manufacturing agreement
To support the development of colorectal cancer treatment
Research & Development
Ark-led consortium wins €5.3m grant
To fund project that combines adenoviral-delivered gene therapeutics and stem cell therapy
Research & Development
Ark wins funding to progress lentiviral technology
Grants awarded by agencies in Finland
Subscribe now